Processa Pharmaceuticals Stock Market Value
| PCSA Stock | USD 3.14 0.05 1.57% |
| Symbol | Processa |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Processa Pharmaceuticals. Anticipated expansion of Processa directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Processa Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Processa Pharmaceuticals using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Processa Pharmaceuticals' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Processa Pharmaceuticals' market price to deviate significantly from intrinsic value.
It's important to distinguish between Processa Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Processa Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Processa Pharmaceuticals' market price signifies the transaction level at which participants voluntarily complete trades.
Processa Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Processa Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Processa Pharmaceuticals.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Processa Pharmaceuticals on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Processa Pharmaceuticals or generate 0.0% return on investment in Processa Pharmaceuticals over 90 days. Processa Pharmaceuticals is related to or competes with Briacell Therapeutics, Curis, Entero Therapeutics, Palisade Bio, Hoth Therapeutics, Moleculin Biotech, and Allarity Therapeutics. Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products ... More
Processa Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Processa Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Processa Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 164.28 | |||
| Value At Risk | (14.08) | |||
| Potential Upside | 11.68 |
Processa Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Processa Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Processa Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Processa Pharmaceuticals historical prices to predict the future Processa Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0082 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (1.67) | |||
| Treynor Ratio | 0.0737 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Processa Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Processa Pharmaceuticals January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0082 | |||
| Market Risk Adjusted Performance | 0.0837 | |||
| Mean Deviation | 8.42 | |||
| Coefficient Of Variation | (53,204) | |||
| Standard Deviation | 18.45 | |||
| Variance | 340.45 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (1.67) | |||
| Treynor Ratio | 0.0737 | |||
| Maximum Drawdown | 164.28 | |||
| Value At Risk | (14.08) | |||
| Potential Upside | 11.68 | |||
| Skewness | 4.23 | |||
| Kurtosis | 31.11 |
Processa Pharmaceuticals Backtested Returns
Processa Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.0255, which implies the firm had a -0.0255 % return per unit of risk over the last 3 months. Processa Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Processa Pharmaceuticals' Coefficient Of Variation of (53,204), variance of 340.45, and Risk Adjusted Performance of 0.0082 to confirm the risk estimate we provide. The company holds a Beta of -0.61, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Processa Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Processa Pharmaceuticals is likely to outperform the market. At this point, Processa Pharmaceuticals has a negative expected return of -0.49%. Please make sure to check Processa Pharmaceuticals' accumulation distribution, and the relationship between the potential upside and day median price , to decide if Processa Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.33 |
Below average predictability
Processa Pharmaceuticals has below average predictability. Overlapping area represents the amount of predictability between Processa Pharmaceuticals time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Processa Pharmaceuticals price movement. The serial correlation of 0.33 indicates that nearly 33.0% of current Processa Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.33 | |
| Spearman Rank Test | 0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 0.43 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Processa Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Processa Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Processa Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Processa Pharmaceuticals Stock:Check out Processa Pharmaceuticals Correlation, Processa Pharmaceuticals Volatility and Processa Pharmaceuticals Alpha and Beta module to complement your research on Processa Pharmaceuticals. For information on how to trade Processa Stock refer to our How to Trade Processa Stock guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Processa Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.